PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses

PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses

Item
http://www.wikidata.org/entity/Q28067141
The role of pembrolizumab in the treatment of advanced non-small cell lung cancerJapanese Kampo medicine ninjin'yoeito synergistically enhances tumor vaccine effects mediated by CD8+ T cellsT-cell epitope strength in WAP-T mouse mammary carcinomas is an important determinant in PD1/PD-L1 immune checkpoint blockade therapy.Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions.Safety and efficacy profile of pembrolizumab in solid cancer: pooled reanalysis based on randomized controlled trials.Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities.Durable Near-Complete Response to Anti-PD-1 Checkpoint Immunotherapy in a Refractory Malignant Solitary Fibrous Tumor of the Pleura.Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition.Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer.Benign form of myasthenia gravis after nivolumab treatment.Nivolumab-induced new-onset seronegative rheumatoid arthritis in a patient with advanced metastatic melanoma: A case report and literature review.Metabolic Symbiosis and Immunomodulation: How Tumor Cell-Derived Lactate May Disturb Innate and Adaptive Immune Responses.Targeting microglia for the treatment of Alzheimer's Disease.Psoriasiform eruption on the face and extremities associated with nivolumab therapy.Anti-PD-1 therapy for clinical treatment of lymphoma: a single-arm meta-analysis
P2860

PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses

Item
http://www.wikidata.org/entity/Q28067141
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses
@ast
PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses
@en
PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses
@nl
type
label
PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses
@ast
PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses
@en
PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses
@nl
prefLabel
PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses
@ast
PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses
@en
PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses
@nl
P1433
P1476
P2093
P275
P2860
P304
P31
P356
P407
P433
P478
P5008
P577
P698
P921
P932
P356
P1433
P1476
PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses
@en
P2093
P275
P2860
P304
P31
P356
P407
P433
P478
P5008
P577
P698
P921
P932